Journal of Diabetes Mellitus
Vol.3 No.4(2013), Paper ID 40054, 8
pages
DOI:10.4236/jdm.2013.34037
Compared with insulin glargine, insulin degludec narrows the day-to-day variability in the glucose-lowering effect rather than lowering blood glucose levels
Susumu Ogawa, Kazuhiro Nako, Masashi Okamura, Miho Senda, Takuya Sakamoto, Sadayoshi Ito
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
Copyright © 2013 Susumu Ogawa, Kazuhiro Nako, Masashi Okamura, Miho Senda, Takuya Sakamoto, Sadayoshi Ito et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Ogawa, S. , Nako, K. , Okamura, M. , Senda, M. , Sakamoto, T. and Ito, S. (2013) Compared with insulin glargine, insulin degludec narrows the day-to-day variability in the glucose-lowering effect rather than lowering blood glucose levels.
Journal of Diabetes Mellitus,
3, 244-251. doi:
10.4236/jdm.2013.34037.